Protocol M13-107: A Phase 1b, Double-Blind, Randomized, Placebo Controlled Study to Evaluate the Safety, Tolerability and Pharmacokinetics of ABT-614 and the Effect of ABT-614 on Glomerular Filtration Rate in Subjects with Type 2 Diabetes and Chronic Kidn